Reuters logo
BRIEF-Veracyte releases statement on CMS's final 2017 gapfill rate for afirma gene expression classifier
2016年10月1日 / 凌晨12点12分 / 1 年前

BRIEF-Veracyte releases statement on CMS's final 2017 gapfill rate for afirma gene expression classifier

Sept 30 (Reuters) - Veracyte Inc :

* Veracyte releases statement on cms’s final 2017 gapfill rate for afirma gene expression classifier

* Believe this new rate is still based on a flawed application of cms gapfill criteria. Plan to file reconsideration request with CMS

Source text for Eikon:

Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below